Tennessee Valley Cooperative Human Tissue Network
Tennessee Valley Cooperative Human Tissue Network
批准号:
10577781
负责人:
MARY Kay WASHINGTON
金额:
$86.11万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2024-03-31
关键词:
Academic Medical CentersAchievementAdherenceAdultAdvocacyAwarenessBasic ScienceBiologicalBiomedical ResearchBusinessesCaringCellsClinicalClinical DataCollectionCommunicationCommunitiesComplexComputer softwareConfidentiality of Patient InformationCooperative Human Tissue NetworkData SetDevelopmentDiseaseDisparity populationEducationEnsureEthicsFeedbackFundingGoalsHumanIndustry StandardInformaticsInfrastructureInternationalLeadershipLinkMalignant NeoplasmsMarketingModelingModernizationPatientsPerformancePlayProcessProductivityPublic HealthQualifyingQuality ControlRare LesionRegulationResearchResearch PersonnelRoleScienceSecurityServicesSiteSocietiesSolidSourceSpecimenSuspensionsSystemTechnologyTennesseeThinnessTissue SampleTissuesTranslational ResearchTumor-Infiltrating Lymphocytesbiobankcost effectivedesignexperiencehuman diseasehuman subject protectionhuman tissueimprovedindividual patientinnovationmemberneoplasticnetwork informaticsnoveloperationpatient engagementprogramsprospectiverepositoryresponsesatisfactionsocial mediatumor progressionweb services
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The Cooperative Human Tissue Network (CHTN) has played an important role since 1987 as a source
for human tissues for biomedical research. To this end, the overarching goal of the Western Division of
the CHTN at Vanderbilt University Medical Center (CHTN-VUMC) is to continue to serve the scientific
community by procuring and distributing adult biospecimens, utilizing a stringent quality management
program to maintain a highly efficient and productive biorepository operation. Key aspects of this goal
are the prospective customized collection of high quality solid tissues and biofluids with clinical
annotation and application of a rigorous Quality Management System to all aspects of the program.
Demographic coverage will be expanded by launching two additional satellite sites for collection. New
services, such as single-cell suspensions, isolation of tumor infiltrating lymphocytes and TMA Build On
Demand in response to changing investigator needs are proposed. In addition preneoplastic and rare
lesions will be banked to facilitate research in tumor progression. The CHTN-VUMC will adhere to
rigorous ethical standards for protection of human subjects and patient confidentiality, and will partner
with the VUMC advocacy program to engage patients and provide opportunities for participation in
research. We also propose to serve as the Informatics (IT) trans-network Coordinating Center
responsible for the second version of the “Investigators IT” system, utilizing web services and a strong
modern technologically advanced platform and ensuring adherence to IT security best practices. In its
divisional IT strategy, CHTN-VUMC will develop and integrate new business models and novel
informatics strategies to improve operational efficiency, including partnering with the VUMC BioVu
project to link tissue samples to large clinical datasets. Marketing efforts will include initiatives to
increase awareness of CHTN in the scientific community, including enhanced use of social media, and
CHTN-VUMC will actively contribute to biorepository science and education through leadership in
societies such as the International Society for Biological and Environmental Repositories.
CHTN-VUMC's leadership in network IT development makes the division uniquely qualified to serve as
the central IT site. A robust track record of specimen distribution, with 64,358 specimens shipped to
1011 investigators over the past 6.5 years, highlights the capabilities of the existing CHTN-VUMC
infrastructure. CHTN-VUMC goals in the next funding period include building upon these foundational
achievements to improve efficiency and communication within the network, investigators and scientific
community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core 1: Tissue Pathology and Cellular Analysis
-
批准号:10218106
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2019
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Core 1: Tissue Pathology and Cellular Analysis
-
批准号:10443608
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2019
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Core 1: Tissue Pathology and Cellular Analysis
-
批准号:10700840
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2019
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Tennessee Valley Cooperative Human Tissue Network
-
批准号:9899210
-
项目类别:
-
资助金额:$91.28万
-
财政年份:2014
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Tennessee Valley Cooperative Human Tissue Network
-
批准号:9247707
-
项目类别:
-
资助金额:$98.9万
-
财政年份:2014
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Tennessee Valley Cooperative Human Tissue Network
-
批准号:10378774
-
项目类别:
-
资助金额:$86.84万
-
财政年份:2014
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Tennessee Valley Cooperative Human Tissue Network
-
批准号:8669436
-
项目类别:
-
资助金额:$98.12万
-
财政年份:2014
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Gastric Histopathology Core
-
批准号:8413060
-
项目类别:
-
资助金额:$18.54万
-
财政年份:2013
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Gastric Histopathology Core
-
批准号:8632354
-
项目类别:
-
资助金额:$17.4万
-
财政年份:2009
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Gastric Histopathology Core
-
批准号:8990359
-
项目类别:
-
资助金额:$4.82万
-
财政年份:2009
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Gastric Histopathology Core
-
批准号:7617408
-
项目类别:
-
资助金额:$20.56万
-
财政年份:2008
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Understanding and Controlling p120 Dysfunction in CRC
-
批准号:7245694
-
项目类别:
-
资助金额:$25.91万
-
财政年份:2007
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Tissue
-
批准号:7245710
-
项目类别:
-
资助金额:$14.48万
-
财政年份:2007
-
负责人:MARY Kay WASHINGTON
-
依托单位:
ARIOL SL-50 WORKSTATION & REVIEW STATIONS: WOUND HEALING & GASTROINTESTINAL DIS
-
批准号:7166660
-
项目类别:
-
资助金额:$6.76万
-
财政年份:2005
-
负责人:MARY Kay WASHINGTON
-
依托单位:
ARIOL SL-50 WORKSTATION AND REVIEW STATIONS: CELL BIOLOGY
-
批准号:7166661
-
项目类别:
-
资助金额:$5.07万
-
财政年份:2005
-
负责人:MARY Kay WASHINGTON
-
依托单位:
ARIOL SL-50 WORKSTATION : BREAST, COLORECTAL, GASTRIC, PROSTATE, & LUNG CANCER
-
批准号:7166659
-
项目类别:
-
资助金额:$21.96万
-
财政年份:2005
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Ariol SL-50 Workstation and Review Stations
-
批准号:6877240
-
项目类别:
-
资助金额:$33.79万
-
财政年份:2005
-
负责人:MARY Kay WASHINGTON
-
依托单位:
HUMAN TISSUE ACQUISITION & PATHOLOGY SHARED RESOURCES
-
批准号:6990165
-
项目类别:
-
资助金额:$12.81万
-
财政年份:2004
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Translational Pathology and Imaging
-
批准号:8343665
-
项目类别:
-
资助金额:$17.53万
-
财政年份:2002
-
负责人:MARY Kay WASHINGTON
-
依托单位:
Preclinical Models of Digestive Diseases
-
批准号:8665900
-
项目类别:
-
资助金额:$36.44万
-
财政年份:2002
-
负责人:MARY Kay WASHINGTON
-
依托单位:
海外基金